Director David J. Matlin filed a Form 4 with the SEC on November 13, 2026, disclosing the acquisition of a stock option covering 6,019 shares of Clene Inc. common stock granted on November 12, 2026.

Key Highlights

  • Reporting person: David J. Matlin, identified as a Director of Clene Inc. (NASDAQ:CLNN).
  • Grant date: November 12, 2026, with the option covering 6,019 shares of common stock.
  • Exercise price: $4.00 per share, under the Clene Inc. Amended 2020 Stock Plan.
  • Vesting: According to the filing, "The options vest immediately upon grant."
  • Expiration date: November 11, 2036, as reported in the filing.
  • Price of derivative security: $0, as listed in Table II of the filing.
  • Beneficial ownership following transaction: 6,019 derivative securities, held directly.

Matlin Receives Immediately Vesting Stock Option Under Clene's 2020 Plan

According to the Form 4 filed on November 13, 2026, David J. Matlin, a director of Clene Inc. (NASDAQ:CLNN), acquired a stock option on November 12, 2026 covering 6,019 shares of Clene common stock. The filing reports the transaction code as "A," indicating an acquisition. The option was granted under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.00 per share and carries an expiration date of November 11, 2036.

The filing notes in its explanation of responses that "This option was granted on November 12, 2026 as an option for 6,019 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.00 per share. The options vest immediately upon grant." The price of the derivative security as listed in Table II is $0. Following this transaction, Matlin is reported to beneficially own 6,019 derivative securities on a direct basis.

No non-derivative securities transactions were reported in Table I of the filing. The Form 4 was signed by Jerome T. Miraglia as power of attorney on November 13, 2026, and was filed as an individual, single-person report rather than a joint or group filing.

What Was Disclosed

Clene Inc. director David J. Matlin disclosed the grant of a stock option for 6,019 shares at a $4.00 exercise price on November 12, 2026, vesting immediately, with an expiration of November 11, 2036, under the company's Amended 2020 Stock Plan.